An expert panel calls the requirement for tuberculosis testing before prescribing IL-17 and IL-23 biologics for psoriasis an ...

Psoriasis is a chronic, immune-mediated skin condition. It causes red, scaly, itchy, often inflamed patches. Because the ...

Innovent Biologics has picked up approval in China for Pecondle, its anti-IL-23p19 antibody, as a treatment for ...

Despite challenges such as high costs and access barriers, the demand for effective, tailored therapies continues to rise, transforming the psoriasis treatment landscapeDublin, Nov. 26, 2025 (GLOBE ...

Innovent Biologics ( ($HK:1801) ) has provided an announcement. Innovent Biologics has announced that its new drug, PECONDLE® (picankibart ...

Psoriasis can affect the fingers, knuckles, nails, palms, and soles. Here’s what this psoriasis looks like and how to relieve symptoms like itch.

TREMFYA® (guselkumab) is now clinically proven to protect joints in active psoriatic arthritis, offering durable efficacy and ...

FOR Dar es Salaam resident Frank Latamani, the chronic skin condition known as Psoriasis has become not only a painful ordeal ...

China: Researchers have found in a new study that secukinumab and ixekizumab demonstrate comparable clinical efficacy for ...

Patients with psoriasis who receive antibiotics may be more likely to discontinue their biologic therapy, a new study suggests. 1 In this French cohort study, the effect increased with multiple ...

In older adults with psoriasis or psoriatic arthritis, use of two biologic classes was associated with lowest rates of serious adverse events than time off those drugs.

With all that in mind, if you have $2,000 available to invest that isn't needed for monthly bills, to pay down short-term ...